Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
1999-04-29
2010-02-09
Lam, Ann Y (Department: 1641)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
Reexamination Certificate
active
07658727
ABSTRACT:
An implantable medical device comprising a drug-loaded polymer overlaid with a fabric that promotes tissue ingrowth is useful in a wide variety of tissue engineering applications. The invention includes, for example, prosthetic heart valves, annuloplasty rings, and grafts, having enhanced biocompatibility and biostability. Methods of making and using the implantable medical devices of the invention are also included.
REFERENCES:
patent: 4348329 (1982-09-01), Chapman
patent: 4506680 (1985-03-01), Stokes
patent: 4577642 (1986-03-01), Stokes
patent: 4585652 (1986-04-01), Miller et al.
patent: 4784161 (1988-11-01), Skalsky et al.
patent: 4873308 (1989-10-01), Coury et al.
patent: 4922926 (1990-05-01), Hirschberg et al.
patent: 4972848 (1990-11-01), Di Domenico et al.
patent: 5002067 (1991-03-01), Berthelsen et al.
patent: 5009229 (1991-04-01), Grandjean et al.
patent: 5092332 (1992-03-01), Lee et al.
patent: 5103837 (1992-04-01), Weidlich et al.
patent: 5229172 (1993-07-01), Cahalan et al.
patent: 5258023 (1993-11-01), Reger
patent: 5265608 (1993-11-01), Lee et al.
patent: 5282844 (1994-02-01), Stokes et al.
patent: 5324324 (1994-06-01), Vachon et al.
patent: 5344438 (1994-09-01), Testerman et al.
patent: 5408744 (1995-04-01), Gates
patent: 5431681 (1995-07-01), Helland
patent: 5447533 (1995-09-01), Vachon et al.
patent: 5447724 (1995-09-01), Helmus et al.
patent: 5449384 (1995-09-01), Johnson
patent: 5510077 (1996-04-01), Dinh et al.
patent: 5554182 (1996-09-01), Dinh et al.
patent: 5591227 (1997-01-01), Dinh et al.
patent: 5599352 (1997-02-01), Dinh et al.
patent: 5607417 (1997-03-01), Batich et al.
patent: 5609629 (1997-03-01), Fearnot et al.
patent: 5624411 (1997-04-01), Tuch
patent: 5645587 (1997-07-01), Chanda et al.
patent: 5679400 (1997-10-01), Tuch
patent: 5716397 (1998-02-01), Myers
patent: 5727555 (1998-03-01), Chait
patent: 5788979 (1998-08-01), Alt et al.
patent: 5869170 (1999-02-01), Cima et al.
patent: 5895419 (1999-04-01), Tweden et al.
patent: 0832655 (1998-04-01), None
patent: 0953320 (1999-11-01), None
patent: 1067118 (1997-05-01), None
patent: WO 82/02829 (1982-09-01), None
patent: WO 91/17744 (1991-11-01), None
patent: WO 95/28899 (1995-11-01), None
patent: WO 96/30060 (1996-03-01), None
patent: WO 97/15245 (1997-05-01), None
patent: WO 98/36784 (1998-09-01), None
European Search Report, Jun. 25, 2008.
Ackerman, et al., “Purification of Human Monocytes on Microexudate-Coated Surfaces”, Journal Immunol., 120:1372-1374, 1978.
Alderson, et al., “A Simple Method of Lymphocyte Purification from Human Peripheral Blood”, Journal lmmunol. Methods, 11:297-301, 1976.
Anderson, “Mechanisms of Inflammation and Infection with Implanted Devices”, Cardiovascular Pathol., 2:335-415, 1993.
Anderson, “Inflammatory Response in Implants”, TASAIO, XXXIV, 101, 1988.
Boyum, et al., “Density-Dependent Separation of White Blood Cells”, Blood Separation and Plasma Fractionation, 217-239, (eds) James Harris, Wiley-Liss, Inc., 1991.
Brais, et al., “Acceleration of Tissue Ingrowth on Materials Implanted in the Heart”, The Annals of Thoracic Surgery, 21:221-229 1976.
Cardona, et al., “TNF and IL-1 Generation by Human Monocytes in Response to Biomaterials”, Journal Biom. Mat. Res., 26:851-859, 1992.
Casas-Bejar, et al., “In vitro Macrophage-Mediated Oxidation and Stress Cracking in a Polyetherurethane”, Transactions of the Fifth World Biomaterials Congress, Toronto, Canada, p. 609, 1996.
Cenni, et al., “Platelet and Coagulation Factor Variations Induced in vitro by Polyethylene Terephithalate (Dacron) Coated with Pyrolytic Carbon”, Biomaterials, 16:973-976, 1995.
French, et al., “Rifampicin Antibiotic Impregnation of the St. Jude Medical Mechanical Valve Sewing Ring: A Weapon Against Endocarditis”, The Journal of Thoracic and Cardiovascular Surgery, 112:248-252, 1996.
Fujimoto, et al., “Ozone-Induced Graft Polymerization onto Polymer Surface”, Journal Polym. Chem., 31:1035-1043, 1993.
Kadoba, et al., Experimental Comparison of Albumin-Sealed and Gelatin-Sealed Knitted Dacron Conduits, The Journal of Thoracic and Cardiovascular Surgery, 103:1059-1067, 1992.
Kao, et al., “Role of Interleukin-4 in Foreign-Body Giant Cell Formation on a Poly(etherurethane area) In vivo”, Journal Biomed. Mat. Res., 29:1267-1275, 1995.
Karck, et al., “Pretreatment of Prosthetic Valve Sewing-ring with the Antibiotic/fibrin Sealant Compound as Prophylactic Tool Against Prosthetic Valve Endocarditis”, Eur. J. Cardio-thorac Surg., 4:142-146, 1990.
Leake, et al., “Comparative Study of the Thromboresistance of Dacron Combined with Various Polyurethanes”, Biomaterials, 10:441-444, 1989.
Marchant, et al., “In vivo Biocompatibilty Studies. I. The Cage Implant System and a Biodegradable Hydrogel”, Journal Biomed. Mat. Res., 17:301-325, 1983.
Miller, et al., “Generation of ILI-like Activity in Response to Biomedical Polymer Implants: A Comparision of in vitro and in vivo Methods”, Journal of Biomed. Mat. Res., 23:1007-1026, 1989.
Miller, et al., “Human Monocyte/Macrophage Activation and Interleukin-1 Generation by Biomedical Polymers”, Journal Biom. Mat. Res., 22:713-731, 1988.
Mond, et al., “The Steroid-Eluting Electrode: A 10-Year Experience”, PACE, 19:1016-1020, 1996.
Onuki, et al., “Accelerated Endothelialization Model for the Study of Dacron Graft Healing”, Annals of Vascular Surgery, 11:141-148, 1997.
Orszulak, et al., “The Risk of Stroke in the early Postoperative Period Following Mitral Valve Replacement”, European Journal of Cardiothoracic Surgery, 9:615-620, 1995.
Perier, et al., “Comparison of Thromboembolic and Anticoagulant-Related Complications After Aortic Valve Replacement Using Starr Edwards, Bjork-Shiley and Porcine Valve Prostheses”, Bodnar E. Yacoub M. (eds). Biologic and Bioprosthetic Valves: York Medical Books, 511-520, 1986.
Rubin, et al., “Preincubation of Dacron Grafts with Recombinant Tissue Factor Pathway Inhibitor Decreases their Thrombogenicity In Vivo”, Journal of Vascular Surg., 24:865-870, 1996.
Schubert, et al., “Oxidative Biodegradation Mechanisms of Biaxially Strained Poly(etherurethane area) Elastomers”, Journal Biomed. Mat. Res., 29:337-347, 1995.
Schwartz, et al., “Local Anticoagulation of Prosthetic Heart Valves”, Circulation, 43 (Suppl III) pp. 85-89, 1973.
Shanbhag, et al., “Macrophase/Particle Interactions: Effects of Size, Composition and Surface Area”, Journal Biomed. Mat. Res., 28:81-90, 1994.
Shankar, et al, “Chapter 5: Inflammation and Biomaterials”, Implantation Biology, Host Response and Biomedical Devices, (eds) Ralph S. Greco, CRC Press, Inc., Boca Raton, FL pp. 67-84, 1994.
Stokes, et al., “Polyurethane Elastomer Biostabillity”, Journal of Biomaterials Applications, 9:321-354, 1995.
Takahashi, “Absorption of Basic Fibroblast Growth factor onto Dacron Vascular Prosthesis and its Biological Efficacy”, Artif Organs, 21:1041-1046, 1997.
Tweden, et al., “Accelerated Healing of Cardiovascular Textiles Promoted by an RGD Peptide”, Journal Heart Valve Dis, 4 (Suppl I), pp. S90-97, 1995.
Van Der Lei, et al., “Improved Healing of Small-Caliber Polyetrafluorethylene Prostheses by Induction of a Clot Layer: A Review of Experimental Studies in Rats”, International Angiology, 10:202-208, 1991.
Wilkerson, et al., Biiomaterials Used in Peripheral Vascular Surgery (eds) Ralph S. Creco, CRC Press, Inc.,, Implantation Biology: The host Responses and Biomedical Devices, pp. 179-190, 1994.
Zhao, et al., “Cellular Interactions and Biomaterials: In vivo Cracking of Pre-stressed Pellethane 2363 80A”, Journal Biom. Mat, Res., 24:621-637, 1990.
Zhao, et al., “Glass Wool-H202/CoCI2 Test System for In Vitro Evaluation of Biodegradative Stress Cracking in Polyurethane
Casas-Bejar Jesus W.
Donovan Maura G.
Fernandes Brian C. A.
Sparer Randall V.
Torrianni Mark W.
Ackley James H.
Collier Kenneth J.
Lam Ann Y
Medtronic Inc
LandOfFree
Implantable medical device with enhanced biocompatibility... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Implantable medical device with enhanced biocompatibility..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable medical device with enhanced biocompatibility... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4171196